Ignite Creation Date:
2025-12-24 @ 5:54 PM
Ignite Modification Date:
2025-12-24 @ 5:54 PM
Study NCT ID:
NCT06725368
Status:
RECRUITING
Last Update Posted:
2025-12-23
First Post:
2024-11-28
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Carboplatin + Paclitaxel + Cetuximab (PCC) After Failure of Pembrolizumab +/- First-line Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Sponsor:
Centre Paul Strauss
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-01-24
Start Date Type:
ACTUAL
Primary Completion Date:
2028-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2032-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-11-28
First Submit QC Date:
None
Study First Post Date:
2024-12-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-17
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED